Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
Sinovac Biotech Accounts Receivable (Quarterly): 425.24M for June 30, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 425.24M |
December 31, 2022 | 497.01M |
June 30, 2022 | 969.56M |
December 31, 2021 | 923.80M |
June 30, 2021 | 1.393B |
December 31, 2020 | 250.63M |
September 30, 2020 | 169.90M |
June 30, 2020 | 106.01M |
March 31, 2020 | 97.60M |
December 31, 2019 | 112.10M |
September 30, 2019 | 104.81M |
June 30, 2019 | 96.58M |
March 31, 2019 | 79.50M |
December 31, 2018 | 72.97M |
June 30, 2018 | 100.41M |
December 31, 2017 | 64.67M |
June 30, 2017 | 81.62M |
December 31, 2016 | 48.46M |
September 30, 2016 | 47.54M |
June 30, 2016 | 29.63M |
March 31, 2016 | 40.13M |
December 31, 2015 | 38.32M |
September 30, 2015 | 46.28M |
June 30, 2015 | 44.14M |
March 31, 2015 | 42.36M |
Date | Value |
---|---|
December 31, 2014 | 39.85M |
September 30, 2014 | 40.85M |
June 30, 2014 | 34.73M |
March 31, 2014 | 36.28M |
December 31, 2013 | 31.31M |
September 30, 2013 | 38.60M |
June 30, 2013 | 31.25M |
March 31, 2013 | 27.34M |
December 31, 2012 | 22.67M |
September 30, 2012 | 25.32M |
June 30, 2012 | 18.53M |
March 31, 2012 | 19.23M |
December 31, 2011 | 16.85M |
September 30, 2011 | 22.13M |
June 30, 2011 | 18.48M |
March 31, 2011 | 22.53M |
December 31, 2010 | 22.37M |
September 30, 2010 | 32.58M |
June 30, 2010 | 26.21M |
March 31, 2010 | 22.71M |
December 31, 2009 | 25.54M |
September 30, 2009 | 36.92M |
June 30, 2009 | 31.74M |
March 31, 2009 | 21.10M |
December 31, 2008 | 19.49M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
96.58M
Minimum
Jun 2019
1.393B
Maximum
Jun 2021
428.86M
Average
210.27M
Median
Accounts Receivable (Quarterly) Benchmarks
CASI Pharmaceuticals Inc | 9.551M |
Zai Lab Ltd | 59.20M |
I-MAB | -- |
Gracell Biotechnologies Inc (DELISTED) | -- |
Adagene Inc | -- |